4D Molecular Therapeutics (FDMT) Return on Sales (QoQ) (2020 - 2026)
4D Molecular Therapeutics (FDMT) Return on Sales (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 |
| Mar 31, 2026 | -31.00 |
| Dec 31, 2025 | 954.00 |
| Sep 30, 2025 | 5,038.00 |
| Jun 30, 2025 | -2,461.00 |
| Mar 31, 2025 | 47,019.00 |
| Dec 31, 2024 | -24,565.00 |
| Sep 30, 2024 | -16,895.00 |
| Jun 30, 2024 | -7,695.00 |
| Mar 31, 2024 | -3,136.00 |
| Dec 31, 2023 | 1,742.00 |
| Sep 30, 2023 | 213.00 |
| Jun 30, 2023 | -49.00 |
| Mar 31, 2023 | -141.00 |
| Dec 31, 2022 | 70.00 |
| Sep 30, 2022 | 117.00 |
| Jun 30, 2022 | -184.00 |
| Mar 31, 2022 | 258.00 |
| Dec 31, 2021 | -251.00 |
| Sep 30, 2021 | -34.00 |